CHARLES RIVER LABORATORIES INTERNATIONAL INC

Display and export data

General & Ratios

Financial Statements

In the 'original' view, the statements are displayed just as they are being reported by the company.

In the 'standardised' view, the statements are displayed in a standardised format (line items are identical for all companies).

Add data

Edit or review data

Legend (for Financial Statements)

Click on a coloured field in the profile to review the data

Close sidebar

Loading: 100%

CHARLES RIVER LABORATORIES INTERNATIONAL... listed company

no logo available

General Information

Investor relations pageIR page	no data available
Founding year	no data available
Headquarter	, , no data available
Employees	11,000 (as per Q2 2017)no data available
Sector	Medical Diagnostics & Research, HealthcareMedical Diagnostics & Research, Healthcareno data available

Ticker	CRLno data available
Financial year endsFY ends	End of Decemberno data available

Stock Information (historical prices adjusted for splits and dividends)

dates	Closing price (adj.)
13.10.2017	112.92
11.10.2017	112.80
04.10.2017	109.58
27.09.2017	107.03
20.09.2017	105.80
13.09.2017	107.53
06.09.2017	107.86
30.08.2017	106.80
23.08.2017	103.66
16.08.2017	99.38
09.08.2017	98.36
02.08.2017	99.53
26.07.2017	99.44
19.07.2017	100.13
12.07.2017	99.97
05.07.2017	101.23
27.06.2017	99.90
20.06.2017	99.10
13.06.2017	94.14
06.06.2017	93.07
30.05.2017	91.79
23.05.2017	90.62
16.05.2017	90.19
09.05.2017	91.70
02.05.2017	90.36
25.04.2017	88.36
18.04.2017	87.69
11.04.2017	87.59
04.04.2017	88.10
28.03.2017	89.36
21.03.2017	88.12
14.03.2017	89.50
07.03.2017	88.12
28.02.2017	86.97
21.02.2017	88.40
14.02.2017	88.95
07.02.2017	82.58
31.01.2017	80.80
24.01.2017	79.28
17.01.2017	79.79
10.01.2017	81.30
03.01.2017	76.53
27.12.2016	76.04
19.12.2016	74.96
12.12.2016	75.06
05.12.2016	72.14
28.11.2016	71.56
21.11.2016	72.44
14.11.2016	75.06
07.11.2016	70.29
31.10.2016	75.88
24.10.2016	82.82
17.10.2016	80.05

no share price data source found

Share price data requested

Key Figures

Last Closing Price as per Oct 13, 2017, in USD	112.92n/a
Market Capitalisation in million USD	5,374n/a
Enterprise Value in million USD	6,420n/a
Common Shares Outstanding as per Jul 28, 2017	47,593,800n/a
Preferred Shares Outstanding as per Jul 28, 2017	n/a
Average Basic Shares Outstanding TTM	47,372,750n/a
Average Diluted Shares Outstanding TTM	48,276,000n/a
Index Membership	, US 1000, US 3000 n/a

Business Summary

Charles River Laboratories International Inc is a pharmaceutical company providing drug discovery and development services. The company provides animal models for laboratory testing, and offers manufacturing testing services to various industries.

no data available

Key Financials & Ratios (all figures TTM as per Jun 30, 2017, million USD, full statements further below)

Profit & Loss

Revenues	1,807n/a
Gross Profit	694n/a
Operating Income	279n/a
EBITDA	0n/a
Net Profit	183n/a

Balance Sheet

Cash and Cash Equivalents	116n/a
Receivables	399n/a
Total Current Assets	738n/a
PP&E	759n/a
Total Assets	2,774n/a
Accounts Payable	65n/a
Current Debt	27n/a
Total Current Liabilities	424n/a
Long-Term Debt	1,116n/a
Total Liabilities	1,792n/a
Total Equity	982n/a

Cash Flow

Depreciation & Amortisation	0n/a
Change in Working Capital	0n/a
Operating Cash Flow	0n/a
Net Change in PP&E and Intangibles	0n/a
Investing Cash Flow	0n/a
Dividends Paid	0n/a
Financing Cash Flow	0n/a
Total Change in Cash	0n/a
Free Cash Flow	0n/a

Profitability Ratios

Gross Margin	38.4%n/a
Operating Margin	15.4%n/a
Net Profit Margin	10.2%n/a
Return on Equity	18.8%n/a
Return on Assets	6.7%n/a

Per Share Figures

Basic EPS	3.87n/a
Diluted EPS	3.79n/a
Sales per Share	38.15n/a
Book Value per Share	20.34n/a
FCF per Share	n/a
Dividends per Share	n/a

Price Multiples

Price to Earnings Ratio	29.21n/a
Price to Sales Ratio	2.96n/a
Price to Book Value	5.45n/a
Price to Free Cash Flow	n/a

Valuation Metrics

EV/EBITDA	n/a
EV/Sales	3.55n/a
Book to Market Value	0.18n/a

Other Ratios

Current Ratio	174.0%n/a
Liabilities to Equity Ratio	182.5%n/a
Debt to Assets Ratio	41.2%n/a

Profit & Loss StatementP&L data quality: 100% (?)

edit

No data available yet

Loading data...

No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.

Standardised statements can't be displayed.

Reason:

No data available for the selected time periods

in million USD	FY '08	FY '09	FY '10	FY '11	FY '12	FY '13	FY '14	FY '15	FY '16
Revenue	1,295	1,172	1,133	1,143	1,130	1,166	1,298	1,363	1,681
Sales & Services Revenue	0	0	0	0	0	0	0	0	0
Financing Revenue	0	0	0	0	0	0	0	0	0
Other Revenue	0	0	0	0	0	0	0	0	0
Cost of revenue	-796	-749	-749	-740	-737	-771	-825	-832	-1,035
Cost of Goods & Services	0	0	0	0	0	0	0	0	0
Cost of Financing Revenue	0	0	0	0	0	0	0	0	0
Cost of Other Revenue	0	0	0	0	0	0	0	0	0
Gross Profit	499	423	385	402	392	395	473	531	647
Other Operating Income	0	0	0	0	0	0	0	0	0
Operating Expenses	-251	-253	-257	-220	-226	-244	-295	-325	-409
Selling, General & Administrative	-224	-228	-232	-199	-208	-226	-269	-300	-368
Selling & Marketing	0	0	0	0	0	0	0	0	0
General & Administrative	0	0	0	0	0	0	0	0	0
Research & Development	0	0	0	0	0	0	0	0	0
Depreciation & Amortization	-27	-26	-24	-22	-18	-18	-26	-24	-42
Provision For Doubtful Accounts	0	0	0	0	0	0	0	0	0
Other Operating Expense	0	0	0	0	0	0	0	0	0
Operating Income (Loss)	248	170	128	182	166	151	178	206	237
Non-Operating Income (Loss)	-20	-18	-36	-42	-36	-13	0	-11	-14
Interest Expense, net	-14	-20	-34	-41	-33	-20	-11	-14	-26
Interest Expense	0	0	0	0	0	0	0	0	0
Interest Income	0	0	0	0	0	0	0	0	0
Other Investment Income (Loss)	0	0	0	0	0	0	0	0	0
Foreign Exchange Gain (Loss)	0	0	0	0	0	0	0	0	0
Income (Loss) from Affiliates	0	0	0	0	0	0	0	0	0
Other Non-Operating Income (Loss)	-5	2	-1	0	-3	7	11	3	12
Pretax Income (Loss), Adjusted	229	152	92	140	130	138	178	195	223
Abnormal Gains (Losses)	-700	0	-426	-7	0	0	0	0	0
Acquired In-Process R&D	0	0	0	0	0	0	0	0	0
Merger / Acquisition Expense	0	0	0	0	0	0	0	0	0
Abnormal Derivatives	0	0	0	0	0	0	0	0	0
Disposal of Assets	0	0	0	0	0	0	0	0	0
Early extinguishment of Debt	0	0	0	0	0	0	0	0	0
Asset Write-Down	0	0	0	0	0	0	0	0	0
Impairment of Goodwill & Intangibles	0	0	0	0	0	0	0	0	0
Sale of Business	0	0	0	0	0	0	0	0	0
Legal Settlement	0	0	0	0	0	0	0	0	0
Restructuring Charges	0	0	0	0	0	0	0	0	0
Sale of and Unrealized Investments	0	0	0	0	0	0	0	0	0
Insurance Settlement	0	0	0	0	0	0	0	0	0
Other Abnormal Items	0	0	0	0	0	0	0	0	0
Pretax Income (Loss)	-471	152	-334	133	130	138	178	195	223
Income Tax (Expense) Benefit, net	-57	-40	0	-17	-28	-33	-48	-43	-67
Current Income Tax	0	0	0	0	0	0	0	0	0
Deferred Income Tax	0	0	0	0	0	0	0	0	0
Tax Allowance/Credit	0	0	0	0	0	0	0	0	0
Income (Loss) from Affiliates, net of taxes	0	0	0	0	0	0	0	0	0
Income (Loss) from Continuing Operations	-528	111	-334	116	102	105	130	152	156
Net Extraordinary Gains (Losses)	3	1	-8	-6	-4	-1	-2	-1	0
Discontinued Operations	3	1	-8	-6	-4	-1	-2	-1	0
XO & Accounting Charges & Other	0	0	0	0	0	0	0	0	0
Income (Loss) Including Minority Interest	-525	113	-342	110	98	104	128	151	156
Minority Interest	1	2	5	0	-1	-1	-2	-2	-2
Net Income	-525	114	-337	110	97	103	127	149	155
Preferred Dividends	0	0	0	0	0	0	0	0	0
Other Adjustments	0	0	0	0	0	0	0	0	0
Net Income Available to Common Shareholders	-525	114	-337	110	97	103	127	149	155

Remarks	restated on Feb 23, 2011 n/a calculated values,	restated on Feb 27, 2012 n/a calculated values,	restated on Feb 27, 2013 n/a calculated values,	restated on Feb 25, 2014 n/a calculated values,	restated on Feb 17, 2015 n/a calculated values,	restated on Feb 12, 2016 n/a calculated values,	restated on Feb 12, 2016 n/a calculated values,	restated on Feb 14, 2017 n/a calculated values,	restated on Feb 14, 2017 n/a calculated values,

Balance SheetBS data quality: 98% (?)

edit

No data available yet

Loading data...

No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.

Standardised statements can't be displayed.

Reason:

No data available for the selected time periods

in million USD	FY '08	FY '09	FY '10	FY '11	FY '12	FY '13	FY '14	FY '15	FY '16
Assets
Cash, Cash Equivalents & Short Term Investments	n/a	183	179	69	110	156	160	118	118
Cash & Cash Equivalents	n/a	183	179	69	110	156	160	118	118
Short Term Investments	n/a	0	0	0	0	0	0	0	0
Accounts & Notes Receivable	n/a	190	193	185	203	221	258	270	364
Accounts Receivable, Net	n/a	190	193	185	203	221	258	270	364
Notes Receivable, Net	n/a	0	0	0	0	0	0	0	0
Unbilled Revenues	n/a	0	0	0	0	0	0	0	0
Inventories	n/a	103	100	93	88	89	89	94	96
Raw Materials	n/a	0	0	0	0	0	0	0	0
Work In Process	n/a	0	0	0	0	0	0	0	0
Finished Goods	n/a	0	0	0	0	0	0	0	0
Other Inventory	n/a	0	0	0	0	0	0	0	0
Other Short Term Assets	n/a	120	80	79	84	87	72	77	79
Prepaid Expenses	n/a	0	0	0	0	0	27	30	34
Derivative & Hedging Assets	n/a	0	0	0	0	0	0	0	0
Assets Held-for-Sale	n/a	8	4	0	0	0	0	0	0
Deferred Tax Assets	n/a	0	0	0	0	0	0	0	0
Income Taxes Receivable	n/a	0	0	0	0	0	0	0	0
Discontinued Operations	n/a	0	0	0	0	0	0	0	0
Miscellaneous Short Term Assets	n/a	112	77	79	84	87	45	47	45
Total Current Assets	n/a	596	553	426	485	553	579	559	657
Property, Plant & Equipment, Net	n/a	864	753	738	717	676	677	678	756
Property, Plant & Equipment	n/a	0	0	0	0	0	0	0	0
Accumulated Depreciation	n/a	0	0	0	0	0	0	0	0
Long Term Investments & Receivables	n/a	0	0	0	0	0	0	0	0
Long Term Investments	n/a	0	0	0	0	0	0	0	0
Long Term Marketable Securities	n/a	0	0	0	0	0	0	0	0
Long Term Receivables	n/a	0	0	0	0	0	0	0	0
Other Long Term Assets	n/a	745	428	394	384	404	615	551	1,299
Intangible Assets	n/a	154	121	93	85	85	179	0	394
Goodwill	n/a	508	198	198	209	231	321	439	788
Other Intangible Assets	n/a	0	0	0	0	0	0	0	0
Prepaid Expense	n/a	0	0	0	0	0	0	0	0
Deferred Tax Assets	n/a	21	45	45	39	27	42	40	29
Derivative & Hedging Assets	n/a	0	0	0	0	0	0	0	0
Prepaid Pension Costs	n/a	0	0	0	0	0	0	0	0
Discontinued Operations	n/a	0	0	0	0	0	0	0	0
Investments in Affiliates	n/a	0	0	0	0	0	0	0	0
Miscellaneous Long Term Assets	n/a	61	63	59	52	62	73	72	88
Total Noncurrent Assets	n/a	1,608	1,180	1,132	1,101	1,080	1,291	1,228	2,055
Total Assets	n/a	2,204	1,733	1,558	1,586	1,633	1,871	1,788	2,712

Liabilities and owners' equity
Payables & Accruals	n/a	125 125264000	139 138914000	130 130311000	123 123377000	147 146943000	173 172764000	199 199001000	246 246426000
Accounts Payable	n/a	31 31218000	31 30627000	34 34332000	31 31218000	32 31770000	34 33815000	37 36675000	68 68485000
Accrued Taxes	n/a	0 0	0 0	0 0	0 0	0 0	0 0	0 0	0 0
Interest & Dividends Payable	n/a	0 0	0 0	0 0	0 0	0 0	0 0	0 0	0 0
Other Payables & Accruals	n/a	94 94046000	108 108287000	96 95979000	92 92159000	115 115173000	139 138949000	162 162326000	178 177941000
Short Term Debt	n/a	35 35413000	31 30582000	15 14758000	139 139384000	21 21437000	32 31904000	17 17033000	27 27313000
Short Term Borrowings	n/a	0 0	0 0	0 0	0 0	0 0	0 0	0 0	0 0
Short Term Capital Leases	n/a	0 0	0 0	0 0	0 0	0 0	0 0	0 0	0 0
Current Portion of Long Term Debt	n/a	0 0	0 0	0 0	0 0	0 0	0 0	0 0	0 0
Other Short Term Liabilities	n/a	89 89096000	90 90284000	72 71728000	79 79486000	79 78654000	90 90018000	96 95727000	156 155854000
Deferred Revenue	n/a	71 71114000	67 66905000	57 56530000	56 56422000	54 54177000	78 78124000	81 81343000	128 127731000
Derivatives & Hedging	n/a	0 0	0 0	0 0	0 0	0 0	0 0	0 0	0 0
Deferred Tax Liabilities	n/a	0 0	0 0	0 0	0 0	0 0	0 0	0 0	0 0
Discontinued Operations	n/a	3 2763000	3 3284000	1 1165000	2 1802000	2 1931000	2 2299000	2 1840000	2 1623000
Miscellaneous Short Term Liabilities	n/a	15 15219000	20 20095000	14 14033000	21 21262000	23 22546000	10 9595000	13 12544000	27 26500000
Total Current Liabilities	n/a	250 249773000	260 259780000	217 216797000	342 342247000	247 247034000	295 294686000	312 311761000	430 429593000
Long Term Debt	n/a	457 457419000	670 670270000	703 703187000	527 527136000	642 642352000	741 740557000	846 845997000	1,208 1207696000
Long Term Borrowings	n/a	0 0	0 0	0 0	0 0	0 0	0 0	0 0	0 0
Long Term Capital Leases	n/a	0 0	0 0	0 0	0 0	0 0	0 0	0 0	0 0
Other Long Term Liabilities	n/a	123 123077000	115 114596000	111 110973000	114 113761000	79 78712000	131 130989000	145 145175000	221 220727000
Accrued Liabilities	n/a	0 0	0 0	0 0	0 0	0 0	0 0	0 0	0 0
Pension Liabilities	n/a	0 0	0 0	0 0	0 0	0 0	0 0	0 0	0 0
Pensions	n/a	0 0	0 0	0 0	0 0	0 0	0 0	0 0	0 0
Other Post-Retirement Benefits	n/a	0 0	0 0	0 0	0 0	0 0	0 0	0 0	0 0
Deferred Compensation	n/a	0 0	0 0	0 0	0 0	0 0	0 0	0 0	0 0
Deferred Revenue	n/a	0 0	0 0	0 0	0 0	0 0	0 0	0 0	0 0
Deferred Tax Liabilities	n/a	0 0	0 0	0 0	0 0	0 0	23 23087000	48 48223000	56 55717000
Derivatives & Hedging	n/a	0 0	0 0	0 0	0 0	0 0	0 0	0 0	0 0
Discontinued Operations	n/a	1 1011000	0 0	3 2522000	9 8795000	8 8080000	8 8357000	8 7890000	6 5771000
Miscellaneous Long Term Liabilities	n/a	122 122066000	115 114596000	108 108451000	105 104966000	71 70632000	100 99545000	89 89062000	159 159239000
Total Noncurrent Liabilities	n/a	580 580496000	785 784866000	814 814160000	641 640897000	721 721064000	872 871546000	991 991172000	1,428 1428423000
Total Liabilities	n/a	830 830269000	1,045 1044646000	1,031 1030957000	983 983144000	968 968098000	1,166 1166232000	1,303 1302933000	1,858 1858016000
Preferred Equity	n/a	0 0	0 0	0 0	0 0	0 0	0 0	0 0	0 0
Share Capital & Additional Paid-In Capital	n/a	2,039 2039226000	1,998 1997649000	2,058 2057706000	2,098 2098112000	2,207 2206980000	2,308 2308485000	2,399 2398815000	2,478 2478234000
Common Stock	n/a	0 0	0 0	0 0	0 0	0 0	0 0	0 0	0 0
Additional Paid in Capital	n/a	0 0	0 0	0 0	0 0	0 0	0 0	0 0	0 0
Other Share Capital	n/a	0 0	0 0	0 0	0 0	0 0	0 0	0 0	0 0
Treasury Stock	n/a	-471 -470527000	-769 -768699000	-1,071 -1071120000	-1,136 -1135609000	-1,306 -1305880000	-1,423 -1423260000	-1,541 -1540738000	-1,553 -1553005000
Retained Earnings	n/a	-238 -238493000	-575 -575162000	-466 -465596000	-368 -368301000	-265 -265473000	-139 -138775000	11 10538000	165 165303000
Other Equity	n/a	45 45037000	34 33635000	5 4593000	7 6603000	5 5357000	-74 -74247000	-136 -135548000	-254 -253764000
Equity Before Minority Interest	n/a	1,375 1375243000	687 687423000	526 525583000	601 600805000	641 640984000	672 672203000	733 733067000	837 836768000
Minority Interest	n/a	-1 -1419000	1 1304000	2 1780000	2 2395000	24 23674000	32 32143000	32 32497000	17 17016000
Total Equity	n/a	1,374 1373824000	689 688727000	527 527363000	603 603200000	665 664658000	704 704346000	766 765564000	854 853784000
Total Liabilities & Equity	n/a	2,204 2204093000	1,733 1733373000	1,558 1558320000	1,586 1586344000	1,633 1632756000	1,871 1870578000	2,068 2068497000	2,712 2711800000

Remarks	restated on n/a	restated on Feb 23, 2011 n/a	restated on Feb 27, 2012 n/a	restated on Feb 27, 2013 n/a	restated on Feb 25, 2014 n/a	restated on Feb 17, 2015 n/a	restated on Feb 12, 2016 n/a	restated on Aug 3, 2016 n/a	restated on Aug 9, 2017 n/a

Cash Flow StatementCF data quality: 3% (?)

edit

No data available yet

Loading data...

No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.

Standardised statements can't be displayed.

Reason:

No data available for the selected time periods

in million USD	FY '08	FY '09	FY '10	FY '11	FY '12	FY '13	FY '14	FY '15	FY '16
Net Income/Starting Line	-525	113	-342	110	98	104	128	151	156
Net Income	0	0	0	0	0	0	0	0	0
Net Income From Discontinued Operations	0	0	0	0	0	0	0	0	0
Other Adjustments	0	0	0	0	0	0	0	0	0
Depreciation & Amortization	87	90	94	85	81	97	96	95	127
Non-Cash Items	750	58	401	45	50	32	30	32	48
Stock-Based Compensation	0	0	0	0	0	0	0	0	0
Deferred Income Taxes	0	0	0	0	0	0	0	0	0
Other Non-Cash Adjustments	0	0	0	0	0	0	0	0	0
Change in Working Capital	-33	-44	8	-28	-26	-25	-4	10	-30
(Increase) Decrease in Accounts Receivable	0	0	0	0	0	0	0	0	0
(Increase) Decrease in Inventories	0	0	0	0	0	0	0	0	0
Increase (Decrease) in Accounts Payable	0	0	0	0	0	0	0	0	0
Increase (Decrease) in Other	0	0	0	0	0	0	0	0	0
Net Cash From Discontinued Operations (operating)	0	0	0	0	0	0	0	0	0
Cash from Operating Activities	279	217	160	213	204	208	250	287	301
Change in Fixed Assets & Intangibles	-199	-80	-43	49	-48	-39	-57	-63	-55
Disposition of Fixed Assets & Intangibles	0	0	0	0	0	0	0	0	0
Disposition of Fixed Assets	0	0	0	0	0	0	0	0	0
Disposition of Intangible Assets	0	0	0	0	0	0	0	0	0
Acquisition of Fixed Assets & Intangibles	0	0	0	0	0	0	0	0	0
Purchase of Fixed Assets	0	0	0	0	0	0	0	0	0
Acquisition of Intangible Assets	0	0	0	0	0	0	0	0	0
Other Change in Fixed Assets & Intangibles	0	0	0	0	0	0	0	0	0
Net Change in Long Term Investment	39	-49	45	56	7	-6	-6	-7	14
Decrease in Long Term Investment	0	0	0	0	0	0	0	0	0
Increase in Long Term Investment	0	0	0	0	0	0	0	0	0
Net Cash From Acquisitions & Divestitures	-69	-83	0	0	-17	-29	-234	-248	-648
Net Cash from Divestitures	0	0	0	0	0	0	0	0	0
Cash for Acqusition of Subsidiaries	0	0	0	0	0	0	0	0	0
Cash for Joint Ventures	0	0	0	0	0	0	0	0	0
Net Cash from Other Acquisitions	0	0	0	0	0	0	0	0	0
Other Investing Activities	0	3	1	-5	3	0	-1	-2	4
Net Cash From Discontinued Operations (investing)	0	0	0	0	0	0	0	0	0
Cash from Investing Activities	-229	-209	3	100	-55	-74	-298	-320	-686
Dividends Paid	0	0	0	0	0	0	0	0	0
Cash From (Repayment of) Debt	-37	-54	-382	253	-140	-523	-195	-417	-657
Cash From (Repayment of) Short Term Debt, net	0	0	0	0	0	0	0	0	0
Cash From (Repayment of) Long Term Debt, net	0	0	0	0	0	0	0	0	0
Repayments of Long Term Debt	0	0	0	0	0	0	0	0	0
Cash From Long Term Debt	0	0	0	0	0	0	0	0	0
Cash From (Repurchase of) Equity	-115	-46	-357	284	-64	-166	-122	-117	-12
Increase in Capital Stock	0	0	0	0	0	0	0	0	0
Decrease in Capital Stock	-115	-46	-357	284	-64	-166	-122	-117	-12
Other Financing Activities	134	19	570	265	93	605	378	539	1,060
Net Cash From Discontinued Operations (financing)	0	0	0	0	0	0	0	0	0
Cash from Financing Activities	-18	-81	-168	802	-111	-84	61	5	391
Net Cash Before Disc. Operations and FX	32	-73	-5	1,114	38	49	14	-28	5
Change in Cash from Disc. Operations and Other	6	10	4	-2	0	-2	-1	-2	-2
Net Cash Before FX	39	-63	-1	1,113	38	48	13	-30	3
Effect of Foreign Exchange Rates	-17	4	-10	-7	-1	-3	-10	-13	-3
Net Changes in Cash	21	-60	-11	1,106	37	45	2	-43	0

Remarks	restated on Feb 23, 2011 n/a calculated values,	restated on Feb 27, 2012 n/a calculated values,	restated on Feb 27, 2013 n/a calculated values,	restated on Feb 25, 2014 n/a calculated values,	restated on Feb 17, 2015 n/a calculated values,	restated on Feb 12, 2016 n/a calculated values,	restated on Feb 14, 2017 n/a calculated values,	restated on Feb 14, 2017 n/a calculated values,	restated on Feb 14, 2017 n/a calculated values,

Some of the data shown on this page is provided for free by IEX